Taiho Oncology Patient Support Services
Taiho Oncology Patient Assistance Program
Taiho Oncology Co-pay Assistance Program
Taiho Oncology offers the Taiho Oncology Patient Support program to help patients while taking Inqovi, Lonsurf, or Lytgobi (Table).
Taiho Oncology Co-pay Assistance Program
Eligible patients with private insurance can enroll in this program to potentially eliminate out-of-pocket costs.
To confirm patient eligibility, call 844-824-4648 or visit Taiho Oncology Co-pay Assistance Program.
Taiho Oncology Patient Assistance Program
This program provides financial assistance for eligible patients who have insufficient or no prescription insurance.
Personalized Nurse Support
When completing the Patient Enrollment Form, you have the option to request personalized nurse support for your patients. If selected, a nurse navigator will be assigned to provide phone support and address general inquiries about the prescribed Taiho Oncology treatment to help patients stay on track with their medication.
Patient Starter Kit
A Patient Starter Kit is available by request for your patients who have been prescribed Lonsurf or Inqovi. This kit contains useful resources to help inform patients and caregivers about all aspects of treatment, including how it works, how it may help, potential side effects, and dosage information. To request a Patient Starter Kit, call 844-824-4648.
To learn more or to enroll your patient in the Taiho Oncology Patient Support program, call 844-824-4648 or visit Taiho Oncology Patient Support.
TABLE Taiho Oncology Drugs
Drugs
Indications
Patient support programs
Drug
Inqovi (decitabine and cedazuridine) tablets
Indications
Treatment of adults with myelodysplastic syndromes, including de novo and secondary myelodysplastic syndrome with the following French-American-British subtypes: refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia; and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups
Patient support programs
Drug
Lonsurf (trifluridine and tipiracil) tablets
Indications
Treatment, alone or in combination with bevacizumab, of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy; an anti-VEGF biological therapy; and if RAS wild-type, an anti-EGFR therapy
Treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least 2 prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy
Patient support programs
Drug
Lytgobi (futibatinib) tablets
Indications
Treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements
Patient support programs
